Cargando…

Sideroflexin1 as a novel tumor marker independently predicts survival in lung adenocarcinoma

BACKGROUND: Targeted therapy for lung cancers is based on prognostic genes and needs more investigation. No study has yet evaluated the effects of Sideroflexin1 (SFXN1) on lung cancer. METHODS: Data were analyzed from large patient cohorts in the Cancer Genome Atlas (TCGA) and the Gene Expression Om...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qijiu, Wang, Rong, Zhang, Jianyong, Zhou, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798550/ https://www.ncbi.nlm.nih.gov/pubmed/35116859 http://dx.doi.org/10.21037/tcr.2019.06.34

Ejemplares similares

Enhanced Inhibitory Effect of DC-CIK Cells on Lung Adenocarcinoma via Anti-Tim-3 Antibody and Antiprogrammed Cell Death-1 Antibody and Possible Mechanism
por: Zhou, Liang, et al.
Publicado: (2022)

Regulation of mitochondrial iron homeostasis by sideroflexin 2
por: Mon, Ei Ei, et al.
Publicado: (2018)

Comprehensive Analysis of Sideroflexin 4 in Hepatocellular Carcinoma by Bioinformatics and Experiments
por: Du, Zhipeng, et al.
Publicado: (2023)

Characterization of Five Transmembrane Proteins: With Focus on the Tweety, Sideroflexin, and YIP1 Domain Families
por: Attwood, Misty M., et al.
Publicado: (2021)

Sideroflexin 3 is an α-synuclein-dependent mitochondrial protein that regulates synaptic morphology
por: Amorim, Inês S., et al.
Publicado: (2017)

The mitochondrial protein Sideroflexin 3 (SFXN3) influences neurodegeneration pathways in vivo
por: Ledahawsky, Leire M., et al.
Publicado: (2022)

Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer
por: Tesfay, Lia, et al.
Publicado: (2022)

Insights into the Roles of the Sideroflexins/SLC56 Family in Iron Homeostasis and Iron-Sulfur Biogenesis
por: Tifoun, Nesrine, et al.
Publicado: (2021)

Tumor microenvironment related novel signature predict lung adenocarcinoma survival
por: Chen, Juan, et al.
Publicado: (2021)

The TIM22 complex mediates the import of sideroflexins and is required for efficient mitochondrial one-carbon metabolism
por: Jackson, Thomas D., et al.
Publicado: (2021)

GBE1 Is an Independent Prognostic Marker and Associated With CD163(+) Tumor-Associated Macrophage Infiltration in Lung Adenocarcinoma
por: Liang, Yicheng, et al.
Publicado: (2022)

Sideroflexin 4 affects Fe-S cluster biogenesis, iron metabolism, mitochondrial respiration and heme biosynthetic enzymes
por: Paul, Bibbin T., et al.
Publicado: (2019)

Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma
por: Massy, E, et al.
Publicado: (2021)

Derivation of a Novel CIHI in Patients with Lung Adenocarcinoma for Estimating Tumor Microenvironment and Clinical Prognosis
por: Zhou, Liang, et al.
Publicado: (2021)

Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
por: Yun, Sumi, et al.
Publicado: (2016)

Sideroflexin 4 is a complex I assembly factor that interacts with the MCIA complex and is required for the assembly of the ND2 module
por: Jackson, Thomas D., et al.
Publicado: (2022)

Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma
por: Liu, Xi, et al.
Publicado: (2018)

Overexpression of eIF3D in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival
por: Wang, Dan, et al.
Publicado: (2019)

Assessment of Serum Tumor Markers for Predicting Ocular Metastasis in Lung Adenocarcinoma: A Retrospective Study
por: Shi, Wen-Qing, et al.
Publicado: (2020)

Orai3 is a predictive marker of metastasis and survival in resectable lung adenocarcinoma
por: Benzerdjeb, Nazim, et al.
Publicado: (2016)

A novel necroptosis signature for predicting survival in lung adenocarcinoma
por: Zang, Kui, et al.
Publicado: (2023)

Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma
por: Li, Zhihua, et al.
Publicado: (2022)

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer
por: Choi, Chang-Min, et al.
Publicado: (2011)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
por: Huang, Jihong, et al.
Publicado: (2022)

Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinoma
por: Hydbring, Per
Publicado: (2022)

A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma
por: Liang, Jin-xiao, et al.
Publicado: (2022)

PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma
por: Zhang, Wenqian, et al.
Publicado: (2020)

Expression of novel tumor markers of pancreatic adenocarcinomas in intrahepatic cholangiocarcinomas
por: Zong, Meijuan, et al.
Publicado: (2013)

Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma
por: Li, Miao, et al.
Publicado: (2020)

Identification of seven‐gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi‐omics data analysis
por: Zhang, Surong, et al.
Publicado: (2021)

Pathologic heterogeneity of lung adenocarcinomas: A novel pathologic index predicts survival
por: Lee, Geewon, et al.
Publicado: (2016)

Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma
por: Duan, Jin, et al.
Publicado: (2021)

A novel nomogram to predict the overall survival of patients with colloid adenocarcinoma of the lung
por: Zhang, Jun, et al.
Publicado: (2021)

Computerized tumor-infiltrating lymphocytes density score predicts survival of patients with resectable lung adenocarcinoma
por: Pan, Xipeng, et al.
Publicado: (2022)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma
por: Zhou, Jiayu, et al.
Publicado: (2018)

RASAL3 predicts overall survival and CD8+ T lymphocyte infiltration in lung adenocarcinoma
por: Liang, Mei, et al.
Publicado: (2022)

An expression signature model to predict lung adenocarcinoma-specific survival
por: Shi, Xiaoshun, et al.
Publicado: (2018)

SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma
por: Huang, Jun, et al.
Publicado: (2016)

A novel CpG island methylation panel predicts survival in lung adenocarcinomas
por: Yan, Pingzhao, et al.
Publicado: (2019)

A novel CpG-based signature for survival prediction of lung adenocarcinoma patients
por: Zheng, Rongjiong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kig0ia7nkdgdi53mbd0phlt80j